US Tech 100

18,064.80

0.02%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ACONW

Aclarion (ACONW)

Aclarion Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACONW

1 2 Next >>

Date	Time	Source	Headline	Symbol	Company
05/15/2024	3:30PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACONW	Aclarion Inc
04/25/2024	9:14AM	GlobeNewswire Inc.	Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain	NASDAQ:ACONW	Aclarion Inc
03/04/2024	8:00AM	GlobeNewswire Inc.	Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs	NASDAQ:ACONW	Aclarion Inc
02/27/2024	3:22PM	GlobeNewswire Inc.	Aclarion Announces Closing of $3.0 Million Public Offering	NASDAQ:ACONW	Aclarion Inc
02/26/2024	9:15AM	GlobeNewswire Inc.	Aclarion Announces Pricing of $3.0 Million Public Offering	NASDAQ:ACONW	Aclarion Inc
02/05/2024	8:00AM	GlobeNewswire Inc.	Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership	NASDAQ:ACONW	Aclarion Inc
01/22/2024	8:00AM	GlobeNewswire Inc.	Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD	NASDAQ:ACONW	Aclarion Inc
01/17/2024	8:00AM	GlobeNewswire Inc.	Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution	NASDAQ:ACONW	Aclarion Inc
01/08/2024	8:00AM	GlobeNewswire Inc.	Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan	NASDAQ:ACONW	Aclarion Inc
01/02/2024	12:00PM	GlobeNewswire Inc.	Aclarion Announces Reverse Stock Split	NASDAQ:ACONW	Aclarion Inc
11/27/2023	8:00AM	GlobeNewswire Inc.	Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams	NASDAQ:ACONW	Aclarion Inc
11/08/2023	8:00AM	GlobeNewswire Inc.	Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption	NASDAQ:ACONW	Aclarion Inc
11/06/2023	8:00AM	GlobeNewswire Inc.	Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD	NASDAQ:ACONW	Aclarion Inc
11/01/2023	8:00AM	GlobeNewswire Inc.	Aclarion Presents at the NIH HEAL Initiative Fall Meeting	NASDAQ:ACONW	Aclarion Inc
10/25/2023	8:30AM	GlobeNewswire Inc.	Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver	NASDAQ:ACONW	Aclarion Inc
10/24/2023	8:45AM	GlobeNewswire Inc.	Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting	NASDAQ:ACONW	Aclarion Inc
10/23/2023	7:00AM	GlobeNewswire Inc.	Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan	NASDAQ:ACONW	Aclarion Inc
10/02/2023	8:00AM	GlobeNewswire Inc.	Aclarion Provides Updated Investor Presentation and Corporate Update	NASDAQ:ACONW	Aclarion Inc
08/25/2023	4:10PM	GlobeNewswire Inc.	Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report	NASDAQ:ACONW	Aclarion Inc
06/14/2023	11:27AM	GlobeNewswire Inc.	Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI	NASDAQ:ACONW	Aclarion Inc
06/08/2023	7:30AM	GlobeNewswire Inc.	Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting	NASDAQ:ACONW	Aclarion Inc
05/30/2023	7:30AM	GlobeNewswire Inc.	Aclarion Announces New Engagement with The London Clinic and London Spine Clinic	NASDAQ:ACONW	Aclarion Inc
05/23/2023	7:30AM	GlobeNewswire Inc.	Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD	NASDAQ:ACONW	Aclarion Inc
05/23/2023	7:00AM	GlobeNewswire Inc.	Aclarion, Inc. Announces Delayed 10-Q Filing	NASDAQ:ACONW	Aclarion Inc
05/19/2023	7:30AM	GlobeNewswire Inc.	Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts	NASDAQ:ACONW	Aclarion Inc
05/02/2023	7:00AM	GlobeNewswire Inc.	Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back Pain	NASDAQ:ACONW	Aclarion Inc
04/28/2023	11:20AM	GlobeNewswire Inc.	Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023	NASDAQ:ACONW	Aclarion Inc
04/24/2023	7:00AM	GlobeNewswire Inc.	Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial	NASDAQ:ACONW	Aclarion Inc
03/07/2023	9:19AM	GlobeNewswire Inc.	Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor	NASDAQ:ACONW	Aclarion Inc
02/15/2023	7:00AM	GlobeNewswire Inc.	Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium	NASDAQ:ACONW	Aclarion Inc